Legal Representation
Attorney
David W. Staple
USPTO Deadlines
Next Deadline
1955 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 26, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 26, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 5, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 7, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin); immune globulin and hyperimmune globulin for pharmaceutical purposes; immune globulin and hyperimmune globulin preparations for the treatment of primary and secondary immunodeficiencies; immune globulin and hyperimmune globulin preparations for the prevention or treatment of infectious diseases; hyperimmune globulin preparation for the prevention or treatment of hepatitis B
First Use Anywhere:
Sep 26, 2019
First Use in Commerce:
Sep 26, 2019
Additional Information
Design Mark
The mark consists of white text over a blue background with the word "ADMA" above the word "BIOLOGICS" to the left of a white droplet shape with yellow shading.
Color Claim
The color(s) blue, yellow and white is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOLOGICS"